139 related articles for article (PubMed ID: 17624254)
21. CD5-positive diffuse large B-cell lymphoma with an unusual phenotype: Cytoplasmic CD20 (+), surface CD20 (-).
Yokose N; Shioi Y; Sugisaki Y; Ohaki Y; Ogata K; Dan K
Leuk Lymphoma; 2006 Jul; 47(7):1415-7. PubMed ID: 16923582
[No Abstract] [Full Text] [Related]
22. [A case of malignant lymphoma associated with diffuse pulmonary involvement successfully treated with rituximab].
Kataoka T; Ishida Y; Kurokawa R; Takeshita S; Ohta K; Nishimura Y; Yokoyama M
Nihon Kokyuki Gakkai Zasshi; 2003 Dec; 41(12):899-904. PubMed ID: 14727553
[TBL] [Abstract][Full Text] [Related]
23. [The age factor in bilateral hydrocele diagnosis secondary to a primitive testis lymphoma: case report, diagnosis and therapy].
Spaziani E; Di Filippo A; Picchio M; De Angelis F; Corazza S; Narilli F; Cimino G
Clin Ter; 2012; 163(1):e23-6. PubMed ID: 22362240
[TBL] [Abstract][Full Text] [Related]
24. Pathogenic study of anti-CD20 infusion-related severe refractory shock in diffuse large B-cell lymphoma.
Gutiérrez A; Rodríguez J; Martínez J; Amezaga R; Ramos R; Galmes B; Bea MD; Ferrer J; Pons J; Sampol A; Morey M; Duran MA; Raurich J; Besalduch J
Leuk Lymphoma; 2006 Jan; 47(1):111-5. PubMed ID: 16321834
[TBL] [Abstract][Full Text] [Related]
25. Large gastrosplenic fistula after effective treatment of abdominal diffuse large-B-cell lymphoma.
Palmowski M; Zechmann C; Satzl S; Bartling S; Hallscheidt P
Ann Hematol; 2008 Apr; 87(4):337-8. PubMed ID: 17929016
[No Abstract] [Full Text] [Related]
26. Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy.
Maeshima AM; Taniguchi H; Nomoto J; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Matsuno Y
Cancer Sci; 2009 Jan; 100(1):54-61. PubMed ID: 19038008
[TBL] [Abstract][Full Text] [Related]
27. Stable remission after administration of rituximab in a patient with primary hepatic marginal zone B-cell lymphoma.
Gockel HR; Heidemann J; Lugering A; Mesters RM; Parwaresch R; Domschke W; Lugering N
Eur J Haematol; 2005 May; 74(5):445-7. PubMed ID: 15813921
[TBL] [Abstract][Full Text] [Related]
28. [Primary diffuse large B-cell lymphoma of testis: a clinicopathologic study of 14 cases].
Li D; Mi C; Zhao Y; Wang YL; Ma Y; Li YY; Xiang MH
Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):461-5. PubMed ID: 17845759
[TBL] [Abstract][Full Text] [Related]
29. A polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphoma.
Racila E; Link BK; Weng WK; Witzig TE; Ansell S; Maurer MJ; Huang J; Dahle C; Halwani A; Levy R; Weiner GJ
Clin Cancer Res; 2008 Oct; 14(20):6697-703. PubMed ID: 18927313
[TBL] [Abstract][Full Text] [Related]
30. Primary diffuse large B-cell lymphoma of the testis relapsing in the right atrium.
Yamamoto E; Tomita N; Ishigatsubo Y
Br J Haematol; 2015 Feb; 168(4):469. PubMed ID: 25403768
[No Abstract] [Full Text] [Related]
31. [Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail].
Lin TY; Zhang HY; Huang Y; Guan ZZ; Shen T; Shi YK; Zhu J; Ke XY; Wang HQ; Shen ZX; Yu SY; Liu T; Shi XL
Ai Zheng; 2005 Dec; 24(12):1421-6. PubMed ID: 16351785
[TBL] [Abstract][Full Text] [Related]
32. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
[TBL] [Abstract][Full Text] [Related]
33. [Cutaneous B-cell lymphoma treatment with rituximab: two cases].
Viguier M; Bachelez H; Brice P; Rivet J; Dubertret L
Ann Dermatol Venereol; 2002 Oct; 129(10 Pt 1):1152-5. PubMed ID: 12442128
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of rituximab plus chemotherapy in follicular lymphoma depends on Ki-67 expression.
Saito B; Shiozawa E; Yamochi-Onizuka T; Adachi D; Nakamaki T; Tomoyasu S; Omine M; Mitsuya T; Takimoto M; Ota H
Pathol Int; 2004 Sep; 54(9):667-74. PubMed ID: 15363034
[TBL] [Abstract][Full Text] [Related]
35. Rituximab for bone lymphoma.
Savage DG; Staron R
Ann Intern Med; 2001 Jun; 134(12):1156-7. PubMed ID: 11412072
[No Abstract] [Full Text] [Related]
36. Discordant expression of CD20 by flow cytometry and immunohistochemistry in a patient responding to rituximab: an unusual mechanism.
Walsh KJ; Al-Quran SZ; Li Y; Braylan RC; Lynch JW
Clin Lymphoma Myeloma; 2007 Jan; 7(4):319-22. PubMed ID: 17324342
[TBL] [Abstract][Full Text] [Related]
37. Preclinical study of Ublituximab, a Glycoengineered anti-human CD20 antibody, in murine models of primary cerebral and intraocular B-cell lymphomas.
Ben Abdelwahed R; Donnou S; Ouakrim H; Crozet L; Cosette J; Jacquet A; Tourais I; Fournès B; Gillard Bocquet M; Miloudi A; Touitou V; Daussy C; Naud MC; Fridman WH; Sautès-Fridman C; Urbain R; Fisson S
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3657-65. PubMed ID: 23611989
[TBL] [Abstract][Full Text] [Related]
38. Malignant lymphoma of the testis presenting as primary testicular tumor.
Saha PK; Sakai H; Nomata K; Minami Y; Kanetake H; Saito Y
Hinyokika Kiyo; 1991 Sep; 37(9):1061-4. PubMed ID: 1785415
[TBL] [Abstract][Full Text] [Related]
39. [Diffuse large B-cell lymphoma of the testis relapsed 16 years after achieving complete response].
Nagasaka I; Mitsui T; Ishizaki T; Koiso H; Yokohama A; Saitoh T; Hirato J; Igarashi T; Kojima M; Tsukamoto N; Nojima Y; Murakami H; Handa H
Rinsho Ketsueki; 2015 Dec; 56(12):2447-51. PubMed ID: 26725353
[TBL] [Abstract][Full Text] [Related]
40. Diffuse large B-cell lymphoma involving the breast. A report of four cases.
Pisani F; Romano A; Anticoli Borza P; Marino M; Micheli A; Botti C; Petti MC
J Exp Clin Cancer Res; 2006 Jun; 25(2):277-81. PubMed ID: 16918141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]